Cross-Sector entity

Aquestive Therapeutics, Inc.

Company AQST
5

Driven Brands Holdings Inc. is the most frequent co-covered peer, appearing in 3 of the 3 tracked stories. The clearest coverage concentration is corporate-law: 1 of 3 stories, with the rest divided among 2 other categories. We currently track 3 Cross-Sector stories that mention Aquestive Therapeutics, Inc., all published on March 13, 2026.

3 verified stories tracked

Last mentioned: Mar 13, 2026

Entity pulse

Recent coverage · Aquestive Therapeutics, Inc.

3 stories
5 avg impact
0% positive
0% negative
  • 100% neutral

Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.

What the coverage shows about Aquestive Therapeutics, Inc.

Driven Brands Holdings Inc. is the most frequent co-covered peer, appearing in 3 of the 3 tracked stories. The clearest coverage concentration is corporate-law: 1 of 3 stories, with the rest divided among 2 other categories. We currently track 3 Cross-Sector stories that mention Aquestive Therapeutics, Inc., all published on March 13, 2026. Each carries 3 original sources on average.

Stories tracked
3
Sources per story
3

Computed from the 3 stories linked to this entity. Beat comparisons are omitted because no baseline was available for this window.

Coverage cohort

Appears alongside

Other entities that clear the same relevance threshold in stories also covering Aquestive Therapeutics, Inc.. Shared-story counts are live from our verified record — not editorial picks.

Stories mentioning Aquestive Therapeutics, Inc. 3

Finance regulation Neutral 5

Pomerantz Law Firm Issues Litigation Deadlines for TCOM, AQST, and DRVN

Pomerantz Law Firm has issued urgent reminders for investors regarding class action lawsuits against Trip.com Group, Aquestive Therapeutics, and Driven Brands Holdings. These legal actions focus on alleged securities violations and material misrepresentations that resulted in significant shareholder losses.

3 sources
Biotech pharma Neutral 5

Aquestive Therapeutics Faces Legal Scrutiny Amid Earnings Miss and Insider Sales

Pomerantz Law Firm has issued a formal reminder to Aquestive Therapeutics (AQST) investors regarding an ongoing class action lawsuit following a period of financial underperformance. The litigation coincides with a recent quarterly earnings miss and notable insider selling, creating a challenging regulatory and legal environment for the biotech firm.

3 sources
Legal corporate law Neutral 5

Pomerantz Law Firm Issues Class Action Deadlines for TCOM, DRVN, and AQST

Pomerantz Law Firm has issued urgent reminders to investors regarding upcoming lead plaintiff deadlines in class action lawsuits against Trip.com Group Limited, Driven Brands Holdings Inc., and Aquestive Therapeutics, Inc. These legal actions allege violations of federal securities laws, primarily focusing on misleading statements or omissions that resulted in significant financial losses for shareholders.

3 sources

Source: prnewswire.com · prnewswire.com